Drug treatment efficiency depends on the initial state of activation in nonlinear pathways

Victoria Doldán-Martelli1, David G Míguez2

  • 1Facultad de Matemáticas, Universidad Carlos III, 28911, Leganés, Madrid, Spain.

Scientific Reports
|August 23, 2018
PubMed

Insights

Drug treatment effectiveness depends on initial network conditions. Our study reveals that network topology and initial states can alter drug response, impacting study reproducibility.

Area of Science:

  • Systems Biology
  • Pharmacology
  • Computational Biology

Background:

  • Accurate drug treatment prediction requires quantitative parameters and understanding molecular interaction networks.
  • The influence of a biological network's initial state on drug efficacy is not fully understood.

Purpose of the Study:

  • To investigate how initial network conditions affect drug inhibition efficiency using in silico screening.
  • To explore the impact of network topology on dose-response curves and drug efficacy.

Main Methods:

  • High-throughput in silico screening of all possible three-node network topologies.
  • Analysis of how initial conditions influence drug inhibition within nonlinear pathway architectures.

Main Results:

  • Most network topologies exhibit multiple dose-response curves, leading to varied drug effects based on initial conditions.
  • The interplay between bistable regimes and node inhibition determines dual responses.
  • Drug efficacy is shown to be dependent on the pathway's initial activation state.

Conclusions:

  • Initial conditions significantly influence drug treatment outcomes and can lead to enhanced, reduced, or absent drug effects.
  • The observed dependence on initial states may explain variability in drug studies and clinical trials.
  • Characterizing network dynamics and initial states is crucial for predicting drug response accurately.

Related Concept Videos

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
689
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
628
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
740